Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Int J Cancer. 2014 Sep 30;136(5):E410–E422. doi: 10.1002/ijc.29229

Table 4.

Odds ratios (ORs) and 95% confidence intervals (CIs) of IUD use and endometrial cancer risk according to endometrial cancer risk factors

Cases Controls OR (95% CI)1 Cases Controls OR (95% CI)1 pinteraction
Age at diagnosis
< 65 years (n=15,386) ≥ 65 years (n=8,745)
IUD use 0.93
  Never 4,464 7,751 Ref 2,904 5,291 0.97 (0.90, 1.05)
  Ever 1,216 1,955 0.81 (0.73, 0.89) 217 333 0.77 (0.63, 0.94)
Parity
Nulliparous (n=3,458) Parous (n=20,531)
IUD use 0.001
  Never 1,477 1,781 Ref 5,826 11,198 0.74 (0.65, 0.85)
  Ever 66 134 0.48 (0.34, 0.68) 1,364 2,143 0.63 (0.54, 0.74)
BMI
<30 kg/m2 (n=18,277) ≥30 g/m2  (n=5,631)
IUD use 0.19
  Never 4,494 10,840 Ref 2,767 2,114 2.83 (2.62, 3.05)
  Ever 974 1,969 0.80 (0.72, 0.88) 445 305 2.34 (1.98, 2.76)
Menopausal status
Premenopausal (n=5,446) Postmenopausal (n=17,497)
IUD use 0.006
  Never 1,182 2,652 Ref 5,732 9,920 0.99 (0.88, 1.11)
  Ever 561 1,051 0.93 (0.80, 1.08) 739 1,106 0.72 (0.62, 0.83)
OC use
Never (n=13,818) Ever (n=9,975)
IUD use 0.26
  Never 4,527 7,846 Ref 2,779 5,063 0.69 (0.64, 0.75)
  Ever 613 832 0.78 (0.68, 0.89) 785 1,348 0.59 (0.53, 0.67)
MHT use2
Never (n=11,095) Ever (n=6,248) 0.008
IUD use
  Never 3,703 6,254 0.69 (0.64, 0.75) 2,000 3,553 Ref
  Ever 481 657 0.57 (0.49, 0.66) 254 441 0.60 (0.50, 0.72)
Smoking status
Never (n=14,648) Former/Current (n=9,338)
IUD use 0.18
  Never 4,765 7,499 Ref 2,559 5,457 0.76 (0.71, 0.82)
  Ever 986 1,398 0.77 (0.69, 0.86) 444 878 0.68 (0.59, 0.79)
Diabetes
No (n=18,275) Yes (n=2,040)
IUD use 0.62
  Never 5,110 10,554 Ref 972 730 1.73 (1.53, 1.95)
  Ever 1,025 1,586 0.81 (0.73, 0.90) 209 129 1.50 (1.17, 1.94)
1

Adjusted for age (continuous), race (White, Black, Asian, Other), BMI (< 25kg/m2, 25–30 kg/m2, ≥30 kg/m2), age at menarche (<11, 11–12, 13–14, ≥15), duration of oral contraceptive use (never, <5, 5–9, ≥10 years), parity/age at last birth (nulliparous, 1–2 births and <25, 1–2 births and 25–29, 1–2 births and 30–34, 1–2 births and ≥35, ≥3 births and <25, ≥3 births and 25–29, ≥3 births and 30–34, ≥3 births and ≥35), menopausal status (premenopausal, postmenopausal), any menopausal hormone use (never, ever), smoking status (never, former, current), and stratified by study. For each effect modifier, women with missing values were excluded from the model

2

Among postmenopausal women